drugset / Trial / NCT02883595
Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether thymosin alpha 1 is effective on improving monocyte function and has the desired pharmacologic activity for sepsis
Timeline
- Start
- 2016-03-31
- Primary completion
- 2016-09-30
- Completion
- 2016-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thymalfasin | Peptide | 1.6 mg | Subcutaneous |